Improved cytotoxicity of DA-125 through high-affinity DNA binding and potent inhibition of Topoisomerase II activity

Sung, M.A. (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742. South Korea and Dong-A Pharmaceutical Research Laboratories, Kyunggi-do 449-900, South Korea) ;
Kang, K.W. (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742. South Korea and Dong-A Pharmaceutical Research Laboratories, Kyunggi-do 449-900, South Korea) ;
Kim, S.H. (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742. South Korea and Dong-A Pharmaceutical Research Laboratories, Kyunggi-do 449-900, South Korea) ;
Son, M.H. (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742. South Korea and Dong-A Pharmaceutical Research Laboratories, Kyunggi-do 449-900, South Korea) ;
Kim, W.B. (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742. South Korea and Dong-A Pharmaceutical Research Laboratories, Kyunggi-do 449-900, South Korea) ;
Kim, S.G. (College of Pharmacy and Research Institute of Pharmaceutical Sciences, Seoul National University, Seoul 151-742. South Korea and Dong-A Pharmaceutical Research Laboratories, Kyunggi-do 449-900, South Korea)